Hib conjugate vaccines: Lessons learned

International Journal of Clinical Practice, Supplement

Volumn , Issue 118, 2001, Pages 8-9

  Scheifele, D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL POLYSACCHARIDE; DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; TETANUS TOXOID;

ANTIBODY TITER; BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; DRUG EFFICACY; DRUG SAFETY; EPIGLOTTITIS; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; MENINGITIS; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION;

CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; TREATMENT OUTCOME; VACCINES, CONJUGATE;

EID: 0035093920     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century; global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates
2. Population-based surveillance of Hib invasive infections in children in British Columbia, Alberta and Ontario - 1995 to 1997
3. Haemophilus influenzae invasive disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease
4. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b
5. Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines
6. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: High efficacy and lack of herd immunity